Abstract Objective To explore the relationship between the expression of endothelial nitric oxide synthase (eNOS) and NADPH oxidase (NOX) in the lungs of mice treated by chronic hypoxic exposure.Methods Thirty male wild-type (WT) C57Bl/6 mice and thirty male eNOS-knockout (KO) C57BL/6 mice were randomly divided into normoxic groups (exposed to normoxia for 7 days or 21 days), hypoxic groups (exposed to 10% oxygen for 7 days or 21 days), and treatment groups (exposed to 10% oxygen and orally administrated 10 mmol/L 4-hydroxy TEMPO in drinking water for 7 days or 21 days) (n=6 in each group). The remodeling of the small pulmonary arteries was evaluated by the percentage of media wall thickness (MT%). The weight ratio of right ventricle to left ventricle plus septum (RV/[LV+S]) was calculated to evaluate the hypertrophy of right ventricle. Real-time PCR was used to measure the mRNA expression of NOX2, NOX4, and eNOS in mouse lungs. ELISA was used to determine the concentration of reactive oxygen species (ROS) in mouse lungs.Results In WT mice and KO mice, the hypoxic groups had significantly increased pulmonary vascular remodeling and RV/[LV+S] compared with the normoxic and treatment groups (P<0.05), but there were no significant differences between the normoxic and treatment groups (P>0.05). In WT mice, the hypoxic and treatment groups had significantly lower ROS concentrations than the normoxic group (P<0.05), but there were no significant differences between the hypoxic and treatment groups (P>0.05). In WT mice, the mRNA expression of eNOS, NOX2, and NOX4 was significantly higher in the hypoxic group than in the normoxic group (P<0.05), and 4-hydroxy TEMPO reversed their over-expression. In the normoxic group, the KO mice had significantly higher NOX2 and NOX4 mRNA expression than the WT mice (P<0.05); in KO mice, the hypoxic group showed no significant changes in NOX4 mRNA expression (P>0.05), but had significantly reduced NOX2 mRNA expression (P<0.05), as compared with the normoxic group; the treatment group had reduced expression of NOX2 mRNA expression and increased NOX4 mRNA expression (P<0.05), as compared with the hypoxic group.Conclusions eNOS plays a key role in the regulation of expression of NOX2 and NOX4 in the lungs exposed to hypoxia. It suggests that NOX and eNOS may physically interact with one another in pulmonary vascular remodeling induced by chronic hypoxia.
WU Xi-Ling,DU Li-Zhong,XU Xue-Feng. Relationship between expression of endothelial nitric oxide synthase and NADPH oxidase in lungs of mice exposed to chronic hypoxia[J]. CJCP, 2015, 17(9): 1001-1006.
WU Xi-Ling,DU Li-Zhong,XU Xue-Feng. Relationship between expression of endothelial nitric oxide synthase and NADPH oxidase in lungs of mice exposed to chronic hypoxia[J]. CJCP, 2015, 17(9): 1001-1006.
Aggarwal S, Gross CM, Sharma S, et al. Reactive oxygen species in pulmonary vascular remodeling[J]. Compr Physiol, 2013, 3(3):1011-1034.
[4]
MacKay CE, Knock GA. Control of vascular smooth muscle function by Src-family kinases and reactive oxygen species in health and disease[J]. J Physiol, 2014. [Epub ahead of print].
[5]
Schulz R, Murzabekova G, Egemnazarov B, et al. Arterial hypertension in a murine model of sleep apnea:role of NADPH oxidase 2[J]. J Hypertens, 2014, 32(2):300-305.
[6]
Chen F, Barman S, Yu Y, et al. Caveolin-1 is a negative regulator of NADPH oxidase-derived reactive oxygen species[J]. Free Radic Biol Med, 2014, 73:201-213.
[7]
Li S, Tabar SS, Malec V, et al. NOX4 regulates ROS levels under normoxic and hypoxic conditions, triggers proliferation, and inhibits apoptosis in pulmonary artery adventitial fibroblasts[J]. Antioxid Redox Signal, 2008, 10(10):1687-1698.
[8]
Frazziano G, Al Ghouleh I, Baust J, et al. Nox-derived ROS are acutely activated in pressure overload pulmonary hypertension:indications for a seminal role for mitochondrial Nox4[J]. Am J Physiol Heart Circ Physiol, 2014, 306(2):H197-H205.
[9]
Norton CE, Broughton BR, Jernigan NL, et al. Enhanced depolarization-induced pulmonary vasoconstriction following chronic hypoxia requires EGFR-dependent activation of NAD(P)H oxidase 2[J]. Antioxid Redox Signal, 2013, 18(14):1777-1788.
[10]
Harrison IP, Selemidis S. Understanding the biology of reactive oxygen species and their link to cancer:NADPH oxidases as novel pharmacological targets[J]. Clin Exp Pharmacol Physiol, 2014, 41(8):533-542.
[11]
Dikalova AE, Góngora MC, Harrison DG, et al. Upregulation of Nox1 in vascular smooth muscle leads to impaired endotheliumdependent relaxation via eNOS uncoupling[J]. Am J Physiol Heart Circ Physiol, 2010, 299(3):H673-H679.
[12]
Rashid M, Kotwani A, Fahim M. Long-acting phosphodiesterase 5 inhibitor, tadalafil, and superoxide dismutase mimetic, tempol, protect against acute hypoxia-induced pulmonary hypertension in rats[J]. Hum Exp Toxicol, 2012, 31(6):626-636.
[13]
Liu JQ, Zelko IN, Erbynn EM, et al. Hypoxic pulmonary hypertension:role of superoxide and NADPH oxidase (gp91phox)[J]. Am J Physiol Lung Cell Mol Physiol, 2006, 290(1):L2-L10.
[14]
Mittal M, Gu XQ, Pak O, et al. Hypoxia induces Kv channel current inhibition by increased NADPH oxidase-derived reactive oxygen species[J]. Free Radic Biol Med, 2012, 52(6):1033-1042.
[15]
Barman SA, Chen F, Su Y, et al. NADPH oxidase 4 is expressed in pulmonary artery adventitia and contributes to hypertensive vascular remodeling[J]. Arterioscler Thromb Vasc Biol, 2014, 34(8):1704-1715.
[16]
Lu X, Murphy TC, Nanes MS, et al. PPAR{gamma} regulates hypoxia-induced Nox4 expression in human pulmonary artery smooth muscle cells through NF-{kappa}B[J]. Am J Physiol Lung Cell Mol Physiol, 2010, 299(4):L559-L566.
[17]
Fuchs B, Sommer N, Dietrich A, et al. Redox signaling and reactive oxygen species in hypoxic pulmonary vasoconstriction[J]. Respir Physiol Neurobiol, 2010, 174(3):282-291.
[18]
Sanchez M, Galisteo M, Vera R, et al. Quercetin downregulates NADPH oxidase, increases eNOS activity and prevents endothelial dysfunction in spontaneously hypertensive rats[J]. J Hypertens, 2006, 24(1):75-84.
[19]
Victor VM, Nuñez C, D'Ocón P, et al. Regulation of oxygen distribution in tissues by endothelial nitric oxide[J]. Circ Res, 2009, 104(10):1178-1183.
[20]
Hodyc D, Snorek M, Brtnicky T, et al. Superoxide dismutase mimetic tempol inhibits hypoxic pulmonary vasoconstriction in rats independently of nitric oxide production[J]. Exp Physiol, 2007, 92(5):945-951.
